Key facts
- This page summarizes Bigalke John T.'s Form 4 filing for PROGENITY, INC. (BIORQ).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 16 Jun 2021, 18:01.
Bigalke John T. - 14 Jun 2021 Form 4 Insider Report for PROGENITY, INC. (BIORQ)
- Reporting relationship
- Director
- Issuer ticker
- BIORQ
- Reported as of
- 14 Jun 2021
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 16 Jun 2021, 18:01:31 UTC
- Next SEC filing
- 07 Dec 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Will Pridgen, Attorney-in-Fact for John T. Bigalke
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Bigalke John T. filed Form 4 for PROGENITY, INC. (BIORQ) on 16 Jun 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BIOR
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +29,183
- Change %
- +159%
- Price
- $0.000000
- Shares after
- 47,518
- Date
- 14 Jun 2021
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
BIOR
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +51,724
- Change %
- Price
- $0.000000
- Shares after
- 51,724
- Date
- 14 Jun 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 51,724
- Exercise price
- $3.17
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Represents 29,183 restricted stock units, which vest in full on the earlier of (1) June 14, 2022 or (2) the date of the Issuer's 2022 annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer.
Footnote F2
This option represents the right to purchase 51,724 shares of the Issuer's common stock, which vest in full on the earlier of (1) June 14, 2022 or (2) the date of the Issuer's 2022 annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer.